Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06210620 · ClinicalTrials.gov registry record

Pro APP Prosthetic Outcome Registry

A clinical trial of Amputation, sponsored by Össur Iceland ehf.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT06210620: Recruiting study of Amputation, sponsored by Össur Iceland ehf.

NCT06210620 is a study of Amputation that is actively recruiting participants, run by Össur Iceland ehf. The registered enrollment target is 2,000 participants, above the 102-participant average among 65 other Amputation trials with a reported enrollment target (1861% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06210620, a study of Amputation, is actively recruiting participants, sponsored by Össur Iceland ehf.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

A national, multi-center registry of patients using lower-limb prosthesis, their profiles and devices, and their long-term follow-up and clinical outcomes.

Primary Outcome

The primary objective of this study is to generate a national, multi-center registry of patients using lower-limb prosthesis, their profiles and devices, and their long-term follow-up and clinical outcomes.

Conditions Studied

Study Locations (1)

California

  • Össur Americas - Irvine

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2024-01-01
Est. Completion 2033-09
Össur Iceland ehf

10 total trials

What NCT06210620 shows while recruiting

NCT06210620 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 102-participant average among 65 other Amputation trials with a reported enrollment target (1861% higher).

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 0 interventions.

NCT06210620 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06210620 about?

NCT06210620 is a clinical study titled "Pro APP Prosthetic Outcome Registry". A national, multi-center registry of patients using lower-limb prosthesis, their profiles and devices, and their long-term follow-up and clinical outcomes.

What is the current status of trial NCT06210620?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-01-01. Estimated completion is 2033-09.

What conditions does trial NCT06210620 study?

This clinical trial studies the following conditions: Amputation.

Who is sponsoring clinical trial NCT06210620?

This trial is sponsored by Össur Iceland ehf, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06210620 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06210620's enrollment target sits among peer trials

2,000 1st of 65 the highest of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06210620, the US trial registry maintained by the National Library of Medicine. NCT06210620 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.